Health notes: a single HIV shot, Louisiana's ALS research and a bilingual scholarship recipient

A single shot at birth may shield children from HIV for years, study finds

A new study led by Tulane researchers and featured in Nature magazine shows that delivering a single injection of gene therapy at birth may offer yearslong protection against HIV.

This treatment takes advantage of a critical window in early life and could reshape the fight against pediatric infections in high-risk regions.

Answer ALS launches AI drug development collaboration with Louisiana research institutions

Answer ALS launched a groundbreaking collaborative initiative in July aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases.

The effort, known as the Louisiana AI Drug Development Infrastructure for ALS, brings together leading institutions and innovators, includin